Ayala Pharmaceuticals Inc Stock, NASDAQ:AYLA
Oppenheimer 4, Suite 5100, Rehovot, Tel Aviv 7670104
United States of America
Number of Employees: 34
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel.